ID   T5 [Human LCL]
AC   CVCL_A6UA
DR   Wikidata; Q107117004
RX   PubMed=15262425;
CC   Population: Japanese.
CC   Karyotypic information: 46,Y,add(X)(p22) (PubMed=15262425).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=15262425
ST   Amelogenin: X,Y
ST   D16S539: 11
ST   D18S51: 15,21
ST   D19S433: 14.2,15.2
ST   D21S11: 31.2,32.2
ST   D2S1338: 24
ST   D3S1358: 15
ST   D8S1179: 13,17
ST   FGA: 23,24
ST   TH01: 7,9
ST   vWA: 16,17
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
RX   PubMed=15262425; DOI=10.1016/j.cancergencyto.2003.11.005;
RA   Sugimoto M., Tahara H., Okubo M., Kobayashi T., Goto M., Ide T.,
RA   Furuichi Y.;
RT   "WRN gene and other genetic factors affecting immortalization of human
RT   B-lymphoblastoid cell lines transformed by Epstein-Barr virus.";
RL   Cancer Genet. Cytogenet. 152:95-100(2004).
//